The guy in the video above is Fred Wilson, a venture capitalist and a partner at Union Square Ventures in New York. (He also a very active and disciplined blogger.) I've blogged about Fred and his thoughts a few times here at DeBordReport.
Watch the whole thing to get a sense of his views on engineering, startups, VC — and where New York might be headed in terms of developing a more diverse startup community.
One of the things that means is biotech.
Biotech is a startup industry that Southern Californian already does and does well. Biotech is our version of Silicon Valley and information technology. And that's good, because biotech could be the next big thing. I went down to Orange County earlier this week to find out how and dropped by a new biotech incubator, TechPortal Orange, at the UC Irvine Medical Center.
There's a problem in the venture capital world. The amount of venture funding flowing into startups has been reduced by the financial crisis, but VCs are still looking to make money off new technology businesses. Biotech is another story. A mobile application or social networking website can turn to gold far quicker than a biomedical play.
"[Information] technology has faster exits than biomedical," said Dr. Jacob Levin, Assistant Vice Chancellor of Research Development at the UC Irvine Medical Center. "The burden of the FDA approval process isn't there. It can take eight years to get a new technology or treatment approved."
According to Levin, the dreaded "valley of death" — the point at which a startup moves from early stage funding to more serious investment, commercialization, and revenue — for biomedical is "expanding." This is a major challenge in Southern California, where biotech is often viewed as the region's answer to Silicon Valley's tech juggernaut.